Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Systematic Review of Case Reports about Korean Medicine for Lung Cancer

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2018, v.39 no.4, pp.136-157
https://doi.org/10.13048/jkm.18041




  • Downloaded
  • Viewed

Abstract

Objectives: This systematic review aimed to put the case reports of lung cancer on Korean medicine (KM) together and adopt the results in clinical practice. Methods: Researches were searched using the PubMed, EMBASE, OASIS, KoreanTK, KISTI, RISS, KISS, and NDSL. The search term were ‘lung cancer’ and KM. There was no restriction in year. Results: 1. Among the 48 studies, 68 patients were reported in total. The types of lung cancer were non-small-cell lung cancer (n=41) and small-cell lung cancer (n=6). 2. The number of patients who received KM therapy alone was 40. On the other hand, 25 patients were treated with KM and chemotherapy simultaneously. All case reports used herbal medicine except 2 studies. Other types of treatment were acupuncture, moxibustion, pharmacopuncture, cupping, meditation, etc. 3. Several efficacy evaluation variables were used such as tumor size, changes of symptoms, duration of survival, the quality of life, and so on. The safety was evaluated by checking adverse effects using blood test. 4. Regarding the tumor response, partial response was reported in 12 cases, stable disease was in 22 cases, 50% of the total cases, which is a high level of tumor response. Furthermore, all 11 cases with the evaluation on the length of survival showed prolonged survival than the expectancy of corresponding stage, with the stable quality of life. Conclusion: We have found that the applicability of KM for treatment of lung cancer through this review. Evidence based medicine can be realized by checking cases and applying them in clinical practice.

keywords
Lung neoplasm’, ‘Medicine, Korean Traditional’, ‘Case reports’, ‘Systematic Review’


Reference

1

1. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92-98.

2

2. American Cancer Society: Cancer Facts & Figures 20OED. Atlanta: American Cancer Society; 2017. Available at: URL:https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/ca ncer-facts-figures-2017.html.

3

3. National Cancer Center. Annual report of cancer statistics in Korea in 2015, Gyeonggi-do:National Cancer Center. 2017 Dec. Available at:URL:http://ncc.re.kr/cancerStatsView.ncc?bbsnu m=438&searchKey=total&searchValue=&page Num=1.

4

4. Kim YH, Kim YT, Kim HK, Park IG, Wu HG, Song SY, et al. Lung cancer guideline. Korean Association for Lung Cancer. 2010.

5

5. Shim JK, Kwon HJ, Jung MK, Oh JM, Park SH, Shin KM, et al. Fatigue and its Related Factors in Lung Cancer Patients on Chemotherapy. The chung-Ang Journal of Nursing 2003;7(1):9-15.

6

6. Hong M, Shim SH, Yoon SH, Choi JY, Kim YS. Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy. Journal of Korean Oriental Internal Medicine. 2017;38(6):917-29.

7

7. Jung HJ, Kim JD. The Role of Korean Medicine for Treatment and Management for Lung Cancer. Journal of Korean Traditional Oncology. 2015:20(1);15-54.

8

8. Nissen T, Wynn R. The history of the case report:a selective review. J R Soc Med. 2014 Mar 12;5(4):1–5.

9

9. Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014;7:264.

10

10. Nissen T, Wynn R. The recent history of the clinical case report: a narrative review. JRSM Short Reports. 2012;3(12):87.

11

11. Smith R. Why do we need Cases Journal? Cases J. 2008;1(1):1.

12

12. Vandenbroucke JP. Case reports in an evidence-based world. J R Soc Med. 1999Apr;92(4):159–163.

13

13. Arnaiz JA, Carne X, Riba N, Codina C, Ribas J, Trilla A. The use of evidence in pharmacovigilance:case reports as the reference source for drug withdrawals. Eur J Clin Pharmacol. 2001;57(1):89-91.

14

14. Caban-Martinez A, Garcia-Beltran WF. Advancing medicine one research note at a time: the educational value in clinical case reports. BMC Research Notes. 2012;5:293.

15

15. Jang SB, et al. A Study on Complementary Alternative Therapy Used by Cancer Patients in Korea. Korean J Adult Nurs. 2006;18(1): 92-101.

16

16. Kim KS, Kim SH, Eo WK, Cheon SH, Eom SK, Jo HJ. Clinical research methodology for Traditional Korean Medicine treatment of Lung cancer: Evidence-based approach. The Journal of Oriental Medical Classics. 2010;23(4):39-62.

17

17. Lee YM. Introduction to Evidence Based Medicine. Vascular Specialist International. 2003;19(2):212-219.

18

18. Firat AC, Araz C, Kayhan Z. Case reports: Should we do away with them? J Clin Anesth. 2017Feb;37:74-76.

19

19. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561–566.

20

g ZF, Yu DQ. Chemical constituents of the stem bark of Morus cathayana. J Asian Nat Prod Res. 2010;12:505-15.

21

20. Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, Ryu JS, et al. National Survey of Lung Cancer in Korea. J Lung Cancer. 2007;6(2):67-73.

22

21. Korean Association of Traditional Oncology. Integrative Oncology of Korean Medicine. Seoul:Gunja. 2013:243.

23

22. Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, Wang MH, et al. Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS One. 2012;7(7):e41586.

24

23. Cheng X, Gu J, Zhang M, Yuan J, Zhao B, Jiang J, et al. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway. Int Immunopharmacol. 2014 Nov;23(1):304-313.

25

24. Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–550.

26

25. Chen S, Flower A, Rirchie A, Liu J, Molassiotis A, Yu H, et al. Oral Chineses herbal medicine as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review. Lung Cancer. 2010:68(2);137-145.

27

26. United Department of Herbology. Herbology. Seoul:Younglimsa. 1991:439.

28

27. Kim KS. Case Study: Regression of a Residual Tumor and Prolongation of Overall Survival with Allergen-removed Rhus verniciflua Stokes after Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer. The Journal of Korean Oriental Internal Medicine. 2015;36(2):200-206.

29

28. Kim JH, Kim HP, Jung CH, Hong MH, Hong MC, Lee SD, et al. Inhibition of cell cycle progression via p27Kip1 upregulation and apoptosis induction by an ethanol extract of Rhus verniciflua stokes in AGS gastric cancer cells. Int J Mol Med 2006;18(1):201-208.

30

29. Jang HS, Kook SH, Son YO, Kim JG, Jeon YM, Jang YS, et al. Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochim Biophys Acta. 2005;1726(3):309-316.

31

30. Lee JD, Huh JE, Jeon G, Yang HR, Woo HS, Choi DY, et al. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol. 2009 Mar;9(3):268-276.

32

31. Cheon SH, Kim KS, Kim S, Jung HS, Choi WC, Eo WK. Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer. Forschende Komplementarmedizin. 2011;18(2):77–83.

33

32. Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS, Choi SJ. Antitumor effect of HangAm-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cancer cell lines. J Korean Oriental Med. 2009;30(5):50-60.

34

33. Yoo HS, Kim SH, Lee YH, Cho CK, Lee KH. Two cases of endometrial cancer treated with palliative herbal medication Hangam-dan (HAD). J Korean Oriental Med. 2007;28(4):176-180.

35

34. Park SC. Yoo HS. Park C. Cho CK. Kim GY. Kim W J. et al. Induction of apoptosis in human lung carcinoma cells by the water extract of Panax notoginseng is associated with the activation of caspase-3 through downregulation of Akt. Int J Oncol. 2009;35(1):121-127.

36

35. Park SE. Yoo HS. Jin CY. Hong SH. Lee YW. 120 Kim BW. et al. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem Toxicol. 2009;47(7):1667-1675.

37

36. Bang JY. Kim EY. Shim TK. Yoo HS. Lee YW. Kim YS. et al. Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B). a Korean traditional medicine, using antibody microarray chip. BioChip ι. 2010;4(4):350-355.

38

37. Lee HJ, Lee G, Y00 HS. Toxicological Study on Hang-Am-Plus in Mice. J Acupunct Meri’dian Stud. 2011;4(1):54-60

39

38. Yang MC, Seo DS, Choi SU, Park YH, Lee KR. Polyacetylenes from the Roots of Cultivated-Wild Ginseng and Their Cytotoxicity In Vitro. Arch Pharm Res. 2008;31(2):154-159.

40

39. Lee JH, Kwon KR, Cho CK, Han SS, Yoo HS. Advanced cancer cases treated with cultivated wild ginseng phamacopuncture. J Acupunct Meridian Stud. 2010;3(2):119-124.

41

40. Seong S. Lung Cancer, the speed is the answer. The Seed Books. 2013:154-155.

42

41. Lee NH, Cho JH, Son CG, Yoo HS, Lee YW, Yoon DH, et al. Analysis of Studies on Quality of Life according to Cancer Types and Symptoms. Korean J Orient Int Med. 2006: 27(3):555-560.

43

42. Lee EH, Park HB, Kim MW, Kang SH, Lee HJ, Lee WH, et al. Analyses of the Studies on Cancer-Related Quality of Life Published in Korea. Radiat Oncol J. 2002;29(4):359-366.

44

43. Seong EJ, Lee MY, Seo CS, Shin HK, Cho JW, Ha H. Sub-acute toxicity and effect of Hwangryunhaedok-tang on human drug-metabolizing enzymes. J Korean Med. 2017;38(2):15-30.

45

44. Luckmann R. Evidence-Based Medicine: How to Practice and Teach EBM, 2nd Edition: By David L. Sackett, Sharon E. Straus, W. Scott Richardson, William Rosenberg, and R. Brian Haynes, Churchill Livingstone, 2000. Journal of Intensive Care Medicine. 2000;16(3):155–156.

46

45. Park BK, Cho CK, Kwon KR, Yoo HS. A Case Report for Stage ⅢB Squamous Cell Lung Carcinoma Patient Treated with Cultured Wild Ginseng Pharmacopuncture Therapy. Journal of pharmacopuncture. 2007;10(3):143-147.

47

46. Lee WC, Shin KS. A Case of Metastatic Brain Tumor Originated from Lung Cancer treated by Oriental Medicine. Journal of Korean Oriental Oncology. 1999;5(1):151-158.

48

47. Cha ES, Jo IH, Lee GG, Jo YM, Jeong HJ, Jeong SG, et al. A Case of Postobstructive Pneumonia in Lung Cancer Patient by Oriental Medical Treatment. Journal of Korean Oriental Oncology. 1997;3(1):207-219.

49

48. Park SJ, Kang HJ, Park JH, Cho CK, Yoo HS. A case report of a clinically diagnosed advanced lung cancer patient after treatment with Gunchilgyebok-Jung. Journal of Korean Traditional Oncology. 2015;20(1):23-29.

50

49. Choi YN, Kim J, Bae K, Cho CK, Yoo HS. A Case of Non-Small Cell Lung Carcinoma Patient Who Improved Skin Rash Due to Olmutinib by Administration of Nobongsangki-Jeong. Journal of Korean Traditional Oncology. 2017;22(1):13-22.

51

50. Lee SH, Lee JS, Jung H, Choi WC, Kim KS. A Case Report of Non-small Cell Lung Cancer with Brain Metastasis Patient Treated with Banhabaekchulchoenma-tang Gagambang. Journal of Korean Traditional Oncology. 2009;14(1):45-52.

52

51. Park SJ, Kang HJ, Lee YW, Cho CK, Yoo HS. A Case Report of a Stage Ⅳ Non-small Cell Lung Cancer Patient Treated with Modified Yieum-jeon Showing Improvement in Malignant Pleural Effusion and other Respiratory Symptoms The Journal of Internal Korean Medicine. 2014. Sep;35(3): 366-372.

53

52. Ha SJ, Song SY, Park SJ, Jeon HJ, Lee YW, Cho CK, et al. A Case of Patient with Non-Small Cell Lung Carcinoma Treated with Samchilchoongcho-Jung in Conjunction with Crizotinib. Journal of Korean Traditional Oncology. 2018;23(1):23-32.

54

53. Park JH, Park SJ, Kang HJ, Cho CK, Han KI, Yoo HS. Tumor-reducing effect of SB injection in a non-small cell lung cancer patient: A case report. Journal of Korean Traditional Oncology. 2014;19(1):61-68.

55

54. Park JH, Cha J, Lee JS, Jung HS, Lee SH, Choi WC, et al. A Case of Non-small Cell Lung Cancer Patient Whose Dermatologic Adverse Reactions Associated with the Epidermal Growth Factor Receptor-inhibitors were Relieved with the Treatment of a Herbal medicine, Samultang-gagambang. Journal of Korean Traditional Oncology. 2011;16(2):55-61.

56

55. Bang SH, Kwon KR, Yoo HS. Two Cases of Non-Small Cell Lung Cancer Treated with Intravenous Cultivated Wild Ginseng Pharmacopuncture. Journal of pharmacopuncture. 2008;11(2):13-19.

57

56. Kim K, Choi YS, Joo JC, Moon G. A Case Report for Lung Cancer Patient Showing Remission Treated with Cultivated Wild Ginseng Pharmacopuncture. Journal of Pharmacopuncture. 2011 Dec;14(4):33-37.

58

57 Park SR, Lee SM, Choi SH, Jung YH, Lee SK. A Case Study of Small-Cell Lung Cancer with Multiple Brain Metastases Patient who Showed Improvement of Delirium and Performance Status. the Journal of Sasang Constitutional Medicine. 2014;25(5):400-408

59

58 Choi BL, Song KC, An JJ, Lim SM, Kim MH, Lee JY, et al. A case study of small cell lung cancer patient. Journal of Oriental Chronic Disease. 2003;9(1):85-91

60

59 Hong M, JH Lee, Park HL, Lee HY, Cho MK, Han CW, et al. Acute Analgesic Effect of Electroacupuncture on a Cancer Pain in a Small Cell Lung Cancer Patient : a Case Report. Korean Journal of Oriental Physiology & Pathology. 2014;28(6):689-694

61

60 Kim MK, Lee JS, Lee SH, Jung HS, Choi WC, Kim KS. A Clinical Case of Patient with Cancer Pain Treated by Moxibustion. Journal of Korean Traditional Oncology. 2009;14(1):53-59

62

61 Song AN, Ahn JH, Kim KS, Jung HS, Lee SK, Choi WC. Long Term Survival of a Patient with Advanced Non-Small Cell Lung Cancer Treated with Allergen Removed Rhus verniciflua Stokes Extract; a Case Report. Journal of Korean Traditional Oncology. 2012;17(1):39-43.

63

62 Kwon EM, Jerng UM, Kim KS, Lee SK, Choi WC, Yoon SW. Two Cases of Non-small Cell Lung Cancer Patients Treated with Allergen Removed Rhus Verniciflua Stokes Based Traditional Korean Medicine and Chemotherapy. Journal of Korean Traditional Oncology. 2009;14(1):13-20

64

63 Yu SM, Eo WK, Yoon SW. One Case Report of Non-small Cell Lung Cancer Patients Treated with Allergen Removed Rhus Verniciflua Stokes(aRVS). Journal of Korean Traditional Oncology. 2008;13(1):63-69

65

64 Choi SH, Song AN, An JH, Kim EH, Park SJ, Lee SK. A Case Report of a Patient with Advanced Non-Small Cell Lung Cancer Treated with Allergen Removed Rhus Verniciflua Stokes (aRVS). Journal of Korean Traditional Oncology. 2012;17(1):45-53

66

65 Park JH, An JH, Lee JS, Jung YH, Lee SH, Cheon SH. A case of the elderly advanced Non-small Cell Lung Cancer Patient Treated with Allergen Removed Rhus Verniciflua Stokes extract. Journal of Korean Traditional Oncology. 2010;15(1);71-77

67

66 Kim EH, Park SJ, Choi WC, Lee Sk. A Case Report of Squamous Cell Lung Cancer Patient Treated with Allergen Removed Rhus Verniciflua Stokes Extract. Journal of Korean Traditional Oncology. 2011;16(2):35-41

68

67 Kang JY, Kim JY, Son CG, Cho JH. Long-Term Survival of Patients with Lung Cancer Treated by Traditional Korean Medicine Combined with Western Treatment: Report of Two Cases. The Journal of Korean Oriental Internal Medicine. 2015;36(1):58-68

69

68 Park SC, Kim DH, Han CW, Park SH, Lee I, Choi JY. Integrated Medicine Therapy for an End-stage Lung Cancer Patient with Brain Metastasis. Journal of Korean Traditional Oncology. 2011;16(1):43-51

70

69 Kim JH, Bae KR, Park SJ, Cho CK, Yoo HS. A Case of Patient with Recurring Non-Small Cell Lung Carcinoma Treated with Samchilchoongcho-Jung in Conjunction with Afatinib. The Journal of Korean Oriental Internal Medicine. 2017;38(1):72-80

71

70 Park JS, Rhee SH, Yim YN, Jung KY, Jun CY, Park CH, et al. A Clinical Report of the Patient with Limited-Stage Small Cell Lung Cancer. The Journal of Korean Oriental Internal Medicine. 2005;26(3):677-684

72

71 Zheng HM, Yoon JW, Lee YW, Cho CK, Oh DS, Yoo HS. Case Series of Advanced Non-Small Cell Lung Cancer Patients Treated with Hang-Am Plus. Journal of Korean Oriental Internal Medicine. 2011;32(1):113-120

73

72 Choi KH, Bang JH, Kim JH, Jung SK, Jung HJ. A Clinical Case Report of a Lung Cancer Patient with Shoulder Pain after Lobectomy. Journal of Korean Traditional Oncology. 2010;15(2):79-87

74

73 Park JW, Jun HJ, Cho CK, Lee YW. One Case Study of a Non Small Cell Lung Cancer Patient Experiencing Gefitinib Adverse Effects Managed by Traditional Korean Medicine. Journal of Korean Traditional Oncology. 2012;17(1):9-16

75

74 Gu JH, Kim SR, Im EY, Kim SJ, Kim JD. One Clinical Case Report of Lung Cancer Patient with Depression and Anxiety Disorder Improved by Korean Traditional Medical Treatment and Breathing Meditation. Korean Journal of Oriental Physiology & Pathology. 2011;25(6):1102-1107

76

75 Choi JH, Yoo HS, Son CG, Cho CK. Regression of small cell lung carcinoma by herbal medicine:a case with an 8-year follow-up. Journal of Korean Traditional Oncology. 2005;10(1):87-91

77

76 Yoo SH, Yoo HS, Cho CK, Lee YW. A Case Report for Recurred Squamous Cell Lung Carcinoma Treated with Hang-Am-Dan : 7-year follow-up. Journal of Korean Oriental Internal Medicine. 2007;28(2):385-390

78

77 Park SR, Lee SM, Lee SK. A Case of the Advanced Non-Small Cell Lung Cancer Patient Who Showed Symptoms Improvement. Journal of Sasang Constitutional Medicine. 2015;27(3):326-332

79

78 Kim KS, Jung TY, Yoo HS, Lee YW, Cho CK. Case Series of Advanced Non-small Cell Lung Cancer Patients Treated with Hang-Am-Plus. Journal of Korean Oriental Internal Medicine. 2009;30(4):893-900

80

79 Lee JS, Park JH, Chae J, Kim KS, Jung HS, Lee SH, et al. Case Report : Long-term Survival and Good-Quality of Life in Metastatic Non-small Cell Lung Cancer Patients Treated with Allergen-removed Rhus verniciflua Stokes (aRVS) as Sequential and Concurrent Treatment with Chemotherapy. Journal of Korean Oriental Internal Medicine. 2011;32(1):129-135

81

80 Son JY, Choi GH, Yoo HJ, Kim HJ, Goo JW, Park MY, et al. One Clinical Case Report of Lung Cancer Patient with Dyspnea Prescribed Oriental Medicine. Journal of Korean Oriental Internal Medicine. 2009;30(1):233-240

82

81 Yi JE, Sun SJ, Jung YS, Kim BW. A Case Report on the Improvement of Lung Cancer Patient's Symptoms by Keumsooyukgun-geun. J of Oriental Chr Dis. 2003;9(1):70-77

83

82 Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative tumor board: case report and discussion from East-West Cancer Center. Integr Cancer Ther. 2010;9(2):236-245

84

83 Lee SH, Kim KS, Choi WC, Yoon SW. The Concurrent Use of Rhus verniciflua Stokes as Complementary Therapy with Second or More Line Regimens on Advanced Non-small-cell Lung Cancer: Case Series. The Journal of Korean Oriental Medicine. 2009;30(6):112-117

85

84 Hong MN, Park HL, Choi JH, Choi JY, Bae GE, Han CW, et al. A Case Report of a Mucinous Adenocarcinoma Patient Treated with Korean Medicine after Wedge Resection of the Lung. J. Int. Korean Med. 2016;37(5):776-785

86

85 Song SY, Jeon H, Lee S. Improvement of Pneumonia in a Patient with Non-Small Cell Lung Cancer Treated with Herbal Medicine after Cessation of Antibiotics – a Case Report. J Korean Med. 2017;38(2):78-84

87

86 Lee SH, Kim KS, Choi WC, Yoon SW. Successful Outcome of Advanced Pulmonary Adenocarcinoma With Malignant Pleural Effusion by the Standardized Rhus Verniciflua Stokes Extract: A Case Study. EXPLORE. 2009;5(4):242-244

88

87 Kim K, Lee S. Remission of Unresectable Lung Metastases from Rectal Cancer After Herbal Medicine Treatment: A Case Report. EXPLORE. 2016;12(4):259-262

89

88 Jang HJ, Lee SA, Sin S, Kim S, Han G. Combined Treatment for Lung Metastasis from Hepatocellular Carcinoma: A Case Report. EXPLORE. 2018;14(5):375-388

90

89 Lim DH, Park KW, Lee SI. Spontaneous Complete Regression of Multiple Metastases of Hepatocellular Carcinoma: A Case Report. Oncology Letters. 2014;7(4):1225-1228

91

90 Lee DH, Kim SS, Shin S, Woo CR, Han JB. A Case of Metastatic Bladder Cancer in Both Lungs Treated with Korean Medicine Therapy Alone. Case Rep Oncol. 2014;7(2):534–540

92

91 Lee DH, Shin S, Kim SS, Han JB. A Case of Stage IV Non-Small Cell Lung Cancer Treated with Korean Medicine Therapy Alone. Case Rep Oncol. 2013;6(3):574–578

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine